FDA Announces Approval of Pharmacogenomic Data Submission Guidance

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a new guidance document on submitting pharmacogenomic data, as required by the Paperwork Reduction Act of 1995.